The Scientist - Home

Current reporting about the contribution of genetic variations to a person’s risk of disease is often incomplete and hard to interpret, according to the authors of a set of best practices for presenting such information.

Patients who received the drug fared better cognitively and functionally than those taking placebo, but still experienced losses in performance.

Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.

In a new study, human and mouse cells recognized only one in five bacterial species collected from more than a mile below the Pacific Ocean’s surface.

Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.

Plant species officially reported to be lost are in fact persevering in the wild, in seed banks or botanical gardens, or as other species now recognized to be taxonomic synonyms.

Clinical trials were halted after the treatment’s vector that ferries in the healthy genetic sequence was identified in the genome of a patient’s cancer cells.

Investigators from underrepresented groups have borne the brunt of the disruption to science from the pandemic, according to an opinion piece that outlines ways in which institutions can lessen the damage.

A National Academies study of COVID-19’s effect on academic researchers adds to the evidence that women’s careers have been particularly damaged by the global disruption.

The link between SARS-CoV-2 and potential stress to kidneys is unclear, but damage to the organs has been documented in adults with COVID-19 too.

Graduate student advocacy groups were central to designing the program, which provides a semester of funding if a trainee needs time to find a new mentor.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.